$IPIX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Innovation Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Innovation Pharmaceuticals Inc.. Get notifications about new insider transactions in Innovation Pharmaceuticals Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2020 | IPIX | Innovation Pharmac ... | EHRLICH LEO | CEO and Chairman | Option Exercise | M | 0.00 | 909,090 | 0 | 1,818,180 | |
| Apr 01 2020 | IPIX | Innovation Pharmac ... | EHRLICH LEO | CEO and Chairman | Option Exercise | M | 0.11 | 909,090 | 100,000 | 4,181,820 | |
| Sep 06 2019 | IPIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Payment of Exercise | F | 0.13 | 9,619 | 1,250 | 150,235 | 159.9 K to 150.2 K (-6.02 %) |
| Sep 06 2019 | IPIX | Innovation Pharmac ... | Bertolino Arthur Peter | President and CMO | Payment of Exercise | F | 0.13 | 421,611 | 54,809 | 2,059,316 | 2.5 M to 2.1 M (-16.99 %) |
| Jan 31 2019 | IPIX | Innovation Pharmac ... | EHRLICH LEO | CEO and Chairman | Option Exercise | A | 0.00 | 909,090 | 0 | 909,090 | |
| Jan 31 2019 | IPIX | Innovation Pharmac ... | EHRLICH LEO | CEO and Chairman | Option Exercise | M | 0.11 | 909,090 | 100,000 | 5,090,910 | |
| Oct 16 2018 | IPIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Payment of Exercise | F | 0.40 | 9,272 | 3,709 | 159,854 | 169.1 K to 159.9 K (-5.48 %) |
| Oct 15 2018 | IPIX | Innovation Pharmac ... | Bertolino Arthur Peter | President and CMO | Payment of Exercise | F | 0.40 | 218,946 | 87,578 | 2,480,927 | 2.7 M to 2.5 M (-8.11 %) |
| Oct 15 2018 | IPIX | Innovation Pharmac ... | Bertolino Arthur Peter | President and CMO | Payment of Exercise | F | 0.40 | 218,946 | 87,578 | 2,480,927 | 2.7 M to 2.5 M (-8.11 %) |
| Sep 24 2018 | IPIX | Innovation Pharmac ... | Bertolino Arthur Peter | President and CMO | Option Exercise | A | 0.40 | 617,839 | 245,900 | 617,839 | |
| Sep 24 2018 | IPIX | Innovation Pharmac ... | Bertolino Arthur Peter | President and CMO | Grant | A | 0.00 | 1,066,667 | 0 | 2,699,873 | 1.6 M to 2.7 M (+65.31 %) |
| Sep 24 2018 | IPIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Option Exercise | A | 0.40 | 172,987 | 68,849 | 172,987 | |
| Sep 24 2018 | IPIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Grant | A | 0.00 | 58,394 | 0 | 169,126 | 110.7 K to 169.1 K (+52.73 %) |
| Dec 27 2017 | IPIX | Innovation Pharmac ... | Bertolino Arthur Peter | President and CMO | Payment of Exercise | F | 0.70 | 238,048 | 166,634 | 1,633,206 | 1.9 M to 1.6 M (-12.72 %) |
| Sep 06 2017 | CTIX | Innovation Pharmac ... | Bertolino Arthur Peter | Pres. & Chief Medic ... | Option Exercise | A | 0.71 | 617,839 | 438,666 | 617,839 | |
| Sep 06 2017 | CTIX | Innovation Pharmac ... | Bertolino Arthur Peter | Pres. & Chief Medic ... | Grant | A | 0.00 | 1,066,667 | 0 | 1,871,254 | 804.6 K to 1.9 M (+132.57 %) |
| Sep 06 2017 | CTIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Option Exercise | A | 0.71 | 172,987 | 122,821 | 172,987 | |
| Sep 06 2017 | CTIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Payment of Exercise | F | 0.71 | 6,056 | 4,300 | 110,732 | 116.8 K to 110.7 K (-5.19 %) |
| Sep 06 2017 | CTIX | Innovation Pharmac ... | Harness Jane A. | Vice President | Grant | A | 0.00 | 58,394 | 0 | 116,788 | 58.4 K to 116.8 K (+100.00 %) |
| Jul 11 2016 | CTIX | Cellceutix CORP | Spektor Zorik | Option Exercise | A | 1.58 | 19,665 | 31,071 | 19,665 | ||
| Jul 07 2016 | CTIX | Cellceutix CORP | Tobin Mark Robert | Option Exercise | A | 1.58 | 19,665 | 31,071 | 19,665 | ||
| Jul 07 2016 | CTIX | Cellceutix CORP | Schechter Barry A | Option Exercise | A | 1.58 | 19,665 | 31,071 | 19,665 | ||
| Jul 07 2016 | CTIX | Cellceutix CORP | Bertolino Arthur Peter | Pres. & Chief Medic ... | Option Exercise | A | 1.39 | 617,839 | 858,796 | 617,839 | |
| Jul 07 2016 | CTIX | Cellceutix CORP | Bertolino Arthur Peter | Pres. & Chief Medic ... | Option Exercise | A | 1.39 | 617,839 | 858,796 | 617,839 | |
| Jul 07 2016 | CTIX | Cellceutix CORP | Bertolino Arthur Peter | Pres. & Chief Medic ... | Grant | A | 0.00 | 1,066,667 | 0 | 1,066,667 | 0 to 1.1 M |
| Jul 07 2016 | CTIX | Cellceutix CORP | Bertolino Arthur Peter | Pres. & Chief Medic ... | Grant | A | 0.00 | 1,066,667 | 0 | 1,066,667 | 0 to 1.1 M |
| Dec 18 2015 | CTIX | Cellceutix CORP | Menon Krishna | President and CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 18,000,000 | |
| Dec 18 2015 | CTIX | Cellceutix CORP | Menon Krishna | President and CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 12,000,000 | |
| Dec 18 2015 | CTIX | Cellceutix CORP | Menon Krishna | President and CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 6,000,000 | |
| Dec 18 2015 | CTIX | Cellceutix CORP | Menon Krishna | President and CSO | Sell | J | 0.00 | 6,000,000 | 0 | 15,048,286 | 21 M to 15 M (-28.51 %) |
| Jan 02 2015 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Gift | G | 0.00 | 50,000 | 0 | 8,585,002 | 8.6 M to 8.6 M (-0.58 %) |
| Sep 02 2014 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 18,000,000 | |
| Sep 02 2014 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 12,000,000 | |
| Sep 02 2014 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 6,000,000 | |
| Sep 02 2014 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Sell | J | 0.00 | 10,000,000 | 0 | 21,048,286 | 31 M to 21 M (-32.21 %) |
| Jan 07 2013 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Gift | G | 0.00 | 110,000 | 0 | 8,635,002 | 8.7 M to 8.6 M (-1.26 %) |
| Jul 30 2012 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 18,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 12,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 6,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Sell | P | 0.00 | 1,000,000 | 0 | 31,048,286 | 32 M to 31 M (-3.12 %) |
| Jul 30 2012 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Buy | J | 0.00 | 32,048,286 | 0 | 32,048,286 | 0 to 32 M |
| Jul 30 2012 | CTIX | Cellceutix CORP | Menon Krishna | President, CSO | Sell | J | 0.00 | 32,048,286 | 0 | 0 | 32 M to 0 (-100.00 %) |
| Jul 30 2012 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Option Exercise | A | 0.51 | 2,000,000 | 1,020,000 | 20,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 18,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 12,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Option Exercise | A | 0.11 | 6,000,000 | 660,000 | 6,000,000 | |
| Jul 30 2012 | CTIX | Cellceutix CORP | EHRLICH LEO | Chief Executive Off ... | Buy | J | 0.00 | 1,000,000 | 0 | 8,745,002 | 7.7 M to 8.7 M (+12.91 %) |
Page: 1